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What was known before:  
• Isolated vitreomacular traction (VMT) has previously been classified based on the 
width of vitreous attachment and the presence of macular hole.  
• Other associated features of VMT are known to occur but no unified classification 
system exists to describe them.   
What this study adds:  
• A simple validated classification system for focal VMT intended to aid in decision-
making and prognostication is described.  
• It is based on optical coherence tomography and hierarchically classifies seven 
features of VMT namely width, vitreo-retinal interface changes, shape, pigment 
epithelial changes, elevation, and inner and outer retinal changes, under the 
pneumonic WISPERR.  
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Abstract 
Purpose: 
To develop and validate a classification system for focal vitreomacular traction (VMT) with 
and without macular hole based on spectral domain optical coherence tomography (SD-
OCT), intended to aid in decision-making and prognostication. 
Methods: 
A panel of retinal specialists convened to develop this system. A literature review followed 
by discussion on a wide range of cases formed the basis for the proposed classification. Key 
features on OCT were identified and analysed for their utility in clinical practice. A final 
classification was devised based on two sequential, independent validation exercises to 
improve inter-observer variability.   
Results: 
This classification tool pertains to idiopathic focal VMT assessed by a horizontal line scan 
using SD-OCT. The system uses width (W), interface features (I), foveal shape (S), retinal 
pigment epithelial changes (P), elevation of vitreous attachment (E) and inner and outer 
retinal changes (R) to give the acronym WISPERR. Each category is scored hierarchically. 
Results from the second independent validation exercise indicated a high level of agreement 
between graders: intra-class correlation ranged from 0.84 to 0.99 for continuous variables 
and Fleiss’ kappa values ranged from 0.76 to 0.95 for categorical variables. 
Conclusions: 
We present an OCT-based classification system for focal VMT that allows anatomical detail 
to be scrutinised and scored qualitatively and quantitatively using a simple, pragmatic 
algorithm, which may be of value in clinical practice as well as future research studies. 
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Introduction 
Advances in optical coherence tomography (OCT) and, in particular, the recent widespread 
adoption of spectral domain OCT (SD-OCT), have provided improved visualisation of the 
vitreoretinal relationships and retinal structure in vitreomacular traction (VMT) syndrome.1,2 
This has enabled observers to differentiate between the focal variant of VMT sometimes 
called vitreofoveolar traction (VFT) and the more broadly adherent form of VMT, where the 
zone of attachment exceeds 1500 microns.3,4 The importance of this differentiation is 
because the latter has a lower probability of undergoing spontaneous separation and, is also 
less responsive to ocriplasmin.5 
Although the diagnosis of focal VMT can be easily made on OCT, no study has yet been 
published detailing those OCT features that might have prognostic significance for either 
spontaneous remission or progression to a full thickness macular hole. Equally it is not clear 
which eyes with focal VMT are best suited for intravitreal ocriplasmin. Indeed published 
series report varying proportions of successful outcome with that treatment modality, as 
well as with spontaneous resolution or response to vitrectomy.6-17  
The recently published report by Duker et al 18 has highlighted the OCT features of both the 
focal and broadly adherent subtypes as well as eyes with focal and broadly adherent 
interfaces where the retinal architecture is not disrupted, termed vitreo-macular adhesion 
(VMA). That group also detailed the presence and absence of macular hole in these cases. 
However the most common presentation of VMT is the focal variant and so there is a need 
for a more detailed classification of the OCT features that occur in both focal VMA and VMT, 
with and without a full thickness macular hole.  
In this study, we describe the creation and validation of a pragmatic, OCT-based 
classification system for focal VMT that can be used in clinical practice or future prospective 
studies to select patients for therapy and evaluate the influence of a wide spectrum of OCT 
changes on therapeutic outcomes. 
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Methods  
A group of UK consultant retinal specialists was convened with the aim of devising a SD-OCT 
based classification tool for eyes with focal vitreo-macular adhesions.  
A PubMed search for relevant published articles was performed, including only those 
written in English and published up to November 2013. Selected relevant papers were 
reviewed prior to the meeting.  
Between November 2013 and March 2014 the group met on two occasions. At the first 
meeting members presented a total of 46 cases of VMT using SD-OCT images from their 
own practices which helped define the proposed structure of the classification tool. Each 
feature of the retinal and vitreoretinal interface was systematically explored, before the key 
elements were identified and reviewed for their utility in assessing VMT in everyday 
practice. 
The group agreed to confine the classification to isolated focal VMA and VMT, and defined 
those entities as a circumscribed area of vitreofoveal attachment of less than 1500 μm in 
diameter, with surrounding vitreoretinal separation, and without other retinal disease. 
VMT, as distinct from VMA, was defined as any associated retinal structural change that was 
attributed to traction. All retinal change associated with traction, including FTMH, could be 
included. Conversely VMA was recognized as an adhesion between the hyaloid and macula, 
but without any structural change in the latter. The minimum scan protocol to be used in 
grading images, in terms of orientation and position, was defined as a horizontal line scan 
using SD-OCT through the foveal centre. 
The classification system was intended to be practical and user friendly, so data fields 
should be easy to collate and quantify as well as having validity in clinical practice. 
The tool was refined and progressed through a number of iterations via email discussions 
and at a second meeting, a further 45 case studies were discussed and classified using the 
prototype tool. A number of exploratory values were added to the classification and a test 
set of 26 new images of focal VMT were collated and distributed. The 26 images were 
selected specifically to allow a range of representative features to be evaluated. Images 
were imported into an open-source image editor (GIMP version 2.8; www.GIMP.org) to 
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allow linear and angular measurements to be made. The nine clinicians graded the images 
independently based on the initial classification system. The original classification system 
used six domains with between two and six categories within each domain, namely: 
1) The width of vitreous attachment: W 
2) The nature of the interface between the vitreous and retina: I 
3) The fovea shape: S 
4) The presence of retinal pigment epithelium changes: P  
5) The elevation of the lowest point of vitreous attachment: E 
6) The nature of associated intra-retinal changes separated into inner and outer retinal 
changes: R  
Categories within each domain were designed to be used in a hierarchical manner. The 
acronym WISPERR was used as a simple reminder of the various domains. In this version of 
the classification several additional parameters were also evaluated:  
a) Subdividing the type of inner retinal change into two groups.  
b) Measuring the angle of vitreous insertion into the retinal surface using the method 
described by Theodossiadis et al.19  
c) Defining the differences between three types of outer retinal change before the 
occurrence of a FTMH. 
d) Evaluating the ability to discern interface hyper-reflectivity in the zone of VMT. 
The test results were analysed for inter-observer agreement using intra-class correlation 
(ICC) for continuous variables and two-way analysis of variance to assess for any systematic 
bias between observers. In addition, we used the method of Jones et al20 to assess 
agreement between observers and to produce an estimate of the limits of agreement with 
the mean. Fleiss’ kappa was used for categorical variables. Fleiss’ kappa is a measure of the 
closeness of agreement between multiple raters employing a categorical scale. The data are 
considered categorical rather than ordinal, so no credit is given for close agreement as in a 
weighted kappa: the latter can only be applied to paired observations. The values of ICC and 
Fleiss’ kappa can be interpreted as follows: 0−0.2 indicates poor agreement: 0.3−0.4 
indicates fair agreement; 0.5−0.6 indicates moderate agreement; 0.7−0.8 indicates strong 
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agreement; and >0.8 indicates almost perfect agreement. We were thus able to provide an 
overall measure of reliability and agreement between the ratings used and evaluate the 
reproducibility of the scale in each category of the proposed classification 
Disagreements were identified and definitions reviewed. Categories with high levels of 
disagreement where separate entities could not be consistently discerned were either 
merged or removed. In particular, the angular measurements and the subdivision of the 
inner retinal changes were removed because of low agreement, and the shape and interface 
classifications were simplified. The definitions of the outer retinal changes were also revised 
to provide greater clarity. Based on these results and discussions a final classification was 
produced and named WISPERR (Table 1, with illustrative figures defining the features used 
shown in Figure 1). A further test set of 10 new cases was reviewed and agreement between 
group members was assessed again. 
Results from both test sets are presented.  
A series of examples of the classification using real images is shown in Figure S1 
(supplementary information online). 
 
Results 
Initial test set of 26 images 
The width of vitreous attachment in the image set ranged from a case of narrow VMT, which 
the observers measured at a mean of 22 μm, to a case of broad VMT measured at a mean of 
1040 μm. The ICC between observers was 0.98 (F=0.84, P=0.67). The measurements showed 
no systematic relationship with width or image and the limit of agreement with the mean 
was 32.3 μm, which we considered clinically acceptable.  
The elevation of the lowest point of vitreoretinal adhesion ranged from a mean of 275 μm 
to a mean of 760 μm. The ICC between observers was 0.84 (F=1.07, P=0.38). The 
measurements showed no systematic relationship with degree of elevation or image and 
the limit of agreement with the mean was 29.6 μm, which was clinically acceptable.  
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For the purposes of the test evaluation the base diameter of outer retinal dehiscence and 
FTMHs were measured. For outer retinal dehiscence (n=7), the base diameter ranged from 
128 μm to 820 μm; the ICC between observers was 0.99 (F=1.22, P=0.31). For FTMHs (n=5), 
the minimum linear diameter ranged from 160 μm to 346 μm; the ICC between observers 
was 0.84 (F=1.84, P=0.15). The measurements showed no systematic relationship with 
width or image and the limit of agreement with the mean was 15.3 μm for base diameter 
and 26.2 μm for the minimum linear diameter.  
The angle of insertion of the vitreous into the retina measured from 12 to 67 degrees on the 
nasal side of the VMT and from 11 to 69 degrees temporally. There was limited variation 
between the mean of observers for all measurements and variation between readers was 
consistent but the ICC showed only moderate agreement (0.69) and ANOVA suggested 
strong evidence of systematic bias between observers (F=5.21, P<0.00001). The limits of 
agreement showed no obvious relationship with angle size but some angles showed tighter 
measurements than others, with the maximum variation in any one angle varying by up to 
27 degrees between observers. The limit of agreement with the mean measured 9.6 
degrees. We considered this to be clinically significant and hence excluded angle 
assessments, as they were too unreliable to be included in the classification.  
Fleiss’ kappa values varied between 0.61 for the vitreoretinal interface and 0.78 for the 
presence of retinal pigment epithelium (RPE) abnormality (Table 2a). 
 
Final test set of 10 images using final grading scheme 
In this test set only the categorical sections were re-evaluated (Table 2b), with improved 
Fleiss’ kappa values of 0.76−0.95. 
 
Discussion  
The proposed classification system focuses on focal VMT (isolated VFT) rather than all types 
of VMT. The International Vitreomacular Traction Study Group recently published a 
10 
 
classification system of vitreoretinal interface abnormalities, including VMT.18 Although 
comprehensive, it is not  sufficiently detailed regarding focal VMT to allow the discovery of 
new prognostic indicators. Other classifications have also been proposed4,8,21 but none to 
date have included the wide range of features that clinicians use to assess focal VMT.  
In a stepwise iterative process, we initially selected vitreoretinal features that were either 
previously known to be important, or those that the group considered may influence VMT 
progression, resolution or response to treatment. Importantly, these characteristics had to 
be easily assessable, with a clear definition to allow acceptable reproducibility in a real-
world (rather than a grading centre) setting. This stepwise system allowed consensus to be 
reached and improved the classification’s validity. The high agreement values in the final 
classification reflect this. We purposefully designed the classification to be hierarchical for 
ease of use. It should be noted that although only OCT features are included in the 
classification, non-OCT features remain important.  
The classification is designed to be used with SD-OCT and principally a single horizontal line 
scan through the foveal centre. Other scans, however, should be utilised to further define 
the extent of the VMA, aid in the detection of eccentric areas of macular hole and ERM, and 
to delineate the maximum values of the minimum linear diameters of FTMHs. It is important 
that the scan through the middle of the foveola is selected. This is defined as the area with 
no bipolar or ganglion cells and where the dark band of the outer nuclear layer extends to 
the foveal surface, without an intervening outer plexiform layer (Figure 2). Clinicians should 
be wary of using eccentric OCT slices as these will confound the assessment. It should also 
be noted when interpreting scans that at the foveal centre on SD-OCT, the area between the 
ellipsoid zone and the retinal pigment epithelium (RPE) can appear slightly lucent and wider 
than adjacent areas. Furthermore, the inner retinal surfaces are brighter on the horizontal 
surfaces, especially nasally where the nerve fibre layer is thickest (Figure 2). 
The width of the VMA is the primary feature for differentiation between classically 
recognised VMT and VFT.4,21 Width has been demonstrated as predictive of treatment 
outcome with intravitreal ocriplasmin9 and shown to be prognostic of spontaneous 
release.22,23 This feature of VMA exists as a continuum rather than a discrete value4,16 and 
we therefore determined that it should be measured. The longest continuous length of 
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adhesion is likely to be the most important in terms of release rather than the sum of 
discontinuous areas of focal VMT, and therefore this was chosen for the classification. 
Although the surface area of the adhesion has been evaluated as a prognostic measure of 
VMT separation23 measuring this in a clinic setting would necessitate a specified scan 
protocol, which varies between machines and centres.  
Concerning the vitreoretinal interface itself, as ERM is known to be a feature of VMT and 
related to both the chance of spontaneous separation and separation induced by 
ocriplasmin, this was included. We separated retinal surface ERM from changes specifically 
at the area of VMT itself and further divided ERM that was contiguous with the zone of VMT 
from non-contiguous ERM. Interface opacity at the zone of VMT, both hyper-reflectivity and 
increased thickness, was found to be a variable feature on the scans examined by the group 
and could be reliably detected. It has previously been shown to be prognostic of release 
with plasmin.24,25 We did not observe any cases of VMT associated with the recently 
described entity of lamellar hole associated epiretinal proliferation.26  
Although the shape of the fovea is currently not known to be a prognostic factor, it is 
important in distinguishing VMT from VMA and correlates with the width of adhesion and 
elevation to suggest the extent of traction. In this study, we sub classified shape into 
normal, loss of inner retinal profile or eversion of fovea. This simple categorisation of shape 
had good agreement between the graders. Eversion of the fovea may prove useful in future 
investigation of visual function in VMT, as found in recent studies on diabetic macular 
oedema.27,28  
The classification was not designed to be used with for VMA in conjunction with other 
diseases, such as wet age-related macular degeneration, diabetic maculopathy or retinal 
vein occlusion. However, we frequently noted that some cases of otherwise isolated VMT 
had concomitant features of ageing, including RPE atrophy and small drusen. Additionally, in 
chronic VMT there can be changes in the uniformity of the RPE pigment with pigment 
migration,29,30 so a simple categorisation of the presence or absence of RPE changes has 
been included. 
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Elevation is an objective measure of the severity of VMT. Many OCT machines provide an 
automated measure of maximum foveal height but with tenuous focal VMT we found that 
segmentation errors were common using automated protocols. We therefore included a 
manual measurement of the height from the RPE to the lowest point of VMA to allow for 
cases with partially avulsed inner retinal flaps.  
It is well established that there is a positive relationship between the tension exerted by 
differing widths of VMT and alterations in retinal architecture.16,19,31 Observation of cases 
has shown that inner retinal changes are more common, and that outer retinal changes can 
range from subtle alterations at the level of the outer segments of the photoreceptors to 
outer retinal dehiscence and FTMHs.32 Recently, however, Almeida et al 22 noted that eyes 
with isolated inner retinal distortion but without outer retinal changes have an apparently 
higher incidence of spontaneous vitreomacular separation than those with outer retinal 
changes. We therefore separated inner retinal change recording from outer retinal change.  
A variety of inner retinal changes have been described and named in tractional 
maculopathies. Some authors have also attempted to differentiate between inner retinal 
changes that may be associated with VMT (variously described as foveal cavitation, foveolar 
cysts, foveal cystoid spaces)33  versus cystoid macular oedema33,29 and retinoschisis.2 We 
found, however, that the observers could not reproducibly differentiate these entities, so a 
single division of present or not present was included. A measure of the degree of inner 
retinal change is also coded within the classification by the elevation measurement.  
Similarly, a large number of outer retinal changes have been described, including a localised 
opalescence of the ellipsoid zone termed the ‘cotton ball’ sign, thought to be due to traction 
at the foveola, which disappears upon vitreoretinal release.25,34 Other changes reported 
include localised defects of the ellipsoid zone and/or exterior limiting membrane, which can 
be associated with the presence of ERM.35–38 These are all included in one category as 
distinguishing between them was inconsistent between observers.  We differentiated 
subretinal fluid from more subtle outer retinal changes and also from outer retinal 
dehiscence seen in impending macular holes. The latter occurs as a result of tractional 
forces on the outer retina.39,40 It has been shown that following treatment of VMT, while 
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intraretinal cystic changes resolve quickly, subretinal fluid resolves more slowly during 
longer follow up.41  
When considering the assessment of FTMH, measurement of the maximum of the minimum 
linear diameter is included, as this measurement has been used in the majority of 
publications to date. It is defined as the width of the narrowest hole diameter using a line 
drawn parallel to the RPE. The narrowest part of the hole should be measured, other than 
that involving the associated retinal operculum—the exact location of the narrowest part of 
the hole varies with the hole configuration (Figure 3). To find the maximum measurement, 
the OCT slice with the widest macular hole width should be used—this can be facilitated by 
using a dense horizontal line scanning protocol or using multiple radial scans. Base diameter 
of macular holes is however, a more reproducible measurement42 and was included to 
quantify the extent of outer retinal dehiscence in cases without FTMH. It is important that in 
cases of outer retinal dehiscence the presence of an eccentric full thickness defect is not 
missed by utilising a dense scanning protocol as with FTMH (Figure 3).  
We initially included the angle of vitreous insertion into the VMT relative to the RPE. 
Theodossiadis et al 17 described an increasing angle of vitreous insertion as being predictive 
of VMT spontaneous resolution. However, this was subsequently removed from the 
classification due to the high variability of measurements between observers. Furthermore, 
although angles may be useful in a research setting their measurement is confounded by a 
number of variables including scan orientation and the aspect ratio the scan is viewed at. 
Furthermore OCT scans are typically presented with the retina viewed as a planar surface 
rather than the reality, which is a concave curved surface,43 which will also alter the VMT 
angles measured.  
In conclusion, we present a novel classification system for focal VMT with details of its 
design and validation. We hope it will serve as a pragmatic system that clinicians could use 
in routine clinical practice and in collaborative research studies to investigate new 
prognostic features related to functional and anatomical outcomes, either with treatment 
or observation.  
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Titles and legends to figures 
 
Table 1 The focal VMT classification tool: WISPERR. 
 
Table 2 Fleiss’ kappa values  
 
Figure 1 Schematic representation of the focal VMT classification tool: WISPERR. (a) Width 
of vitreous attachment (W), interface features (I) and foveal shape (S). (b) Retinal pigment 
epithelial changes (P), elevation of vitreous attachment (E) and inner and outer retinal 
changes (R). 
 
Figure 2 Horizontal SD-OCT of a normal fovea. *Note pre-macula bursa.  
 
Figure 3 Examples of minimum linear diameter measurements using SD-OCT slice with 
maximum hole dimensions. In A the minimum linear diameter is on the inner side of the 
hole and in an eccentric slice without vitreomacular traction, whilst in B it is on the outer 
retinal side of the hole. C shows a case of apparent outer retinal dehiscence but with a tiny 
para-central full thickness macular hole seen on one more eccentric OCT slice in D. When 
measuring minimum linear diameter, the area of the retinal operculum should not be 
included (shown in E and F).  
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[Supplementary information] 
 
A series of examples of the WISPERR classification system using real OCT images. 
 
Supplementary Figure S1a Examples of focal vitreomacular traction with or without full 
thickness macular hole classified using the WISPERR system. 
 
Supplementary Figure S1b Examples of focal vitreomacular traction with or without full 
thickness macular hole classified using the WISPERR system. 
 
Supplementary Figure S1c Examples of focal vitreomacular traction with or without full 
thickness macular hole classified using the WISPERR system. 
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Table 1 The focal VMT classification tool: WISPERR. 
Letter Feature classified Description of measurement 
technique or feature  
Units of measurement or graded categories
W 
 
Width of vitreo-macular 
attachment  
Width of longest measurable 
vitreo-macular adhesion extent on 
any scan which is connected to the 
foveal centre—if there are multiple 
areas of adhesion  the longest 
single one should be used.  
 
Measurement in microns.
 
I Interface between retina 
and vitreous cavity 
 
Surface membrane.
 
0) None.
 
1) Hyper-reflective inner retinal signal on the VMA itself compared to adjacent 
retina (indicative of thickened ILM and can include thickened ILM alone and/or 
pre ILM material which has not met criteria for an ERM). 
 
2) Any ERM on any part of the area of retina encompassed by the OCT 
(signified by a discrete line anterior to ILM surface, retinal corrugations and 
discrete areas of high signal on ILM). 
 
3) Any ERM within the central 1-mm ETDRS circle or contiguous with the zone 
of VMT. 
 
S Shape  
 
Foveal shape based on foveal 
profile and position as compared to 
surrounding retina.  
0) Normal.
 
1) Abnormal profile with loss of smooth contour e.g. notch formation, concave 
with loss of depression relative to other side, asymmetry of depression or flat 
profile.  
 
2) Clear eversion of the central foveola with a convex profile of the central 
fovea.  
 
P Pigment epithelium Presence of RPE abnormalities in 
central ETDRS 1-mm diameter 
circle. 
 
0) Not present.
 
1) Present (could include drusen and/or RPE atrophy). 
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E Elevation of retinal 
surface from RPE 
Height of maximum central retinal 
thickness in central 1-mm diameter 
ETDRS circle—measured from 
inner surface of RPE to maximum 
retinal elevation and therefore 
including any SRF.*  
Measurement in microns.*  
 
R1 Inner retina Inner retinal changes within central 
3-mm ETDRS circle. 
 
0) Normal.
 
1) Inner retinal cysts or cleavage. 
  
R2 Outer Retina Outer retinal changes within 
central 3-mm ETDRS circle.  
 
 
0) None.
 
1) Focal outer retinal abnormality (including ‘cotton ball’ sign, IS/OS/ELM 
disruption/fragmentation) without SRF, or dehiscence . 
 
2) SRF with outer retinal separation of the photoreceptors from the RPE with 
upward displacement of IS/OS and ELM lines (including with hypo- or hyper-
reflective filling of the resultant space). Usually associated with irregularity of 
photoreceptor outer segments but no actual defects or dehiscence  
 
3) Outer retinal dehiscence, i.e. sharply-defined defect in the outer retina 
involving at least the ellipsoid zone and ELM secondary to photoreceptor 
separation with a layer of intact inner retina. Size of defect measured as base 
diameter.** 
 
4) Full thickness macular hole and ‘maximum minimum’ horizontal linear 
dimension.***  
 
*Many OCT systems measure this in an automated way but it is best measured manually to avoid segmentation errors. In cases where there is a 
partially avulsed flap of retina or an oblique highest point, the height to the lowest point of contiguous vitreoretinal adhesion should be used. 
**The maximum base diameter should be  measured horizontally from the two junctions of the outer retina with RPE. A dense scanning protocol should 
be followed to avoid missing small eccentric full thickness macular holes. 
***The maximum of the minimum linear diameter is measured—this is defined as the narrowest hole diameter in the mid-retina using a line drawn 
parallel to the RPE. The narrowest part of hole should be measured other than that involving the hole operculum. To find the maximum measurement 
the OCT slice with the widest macular hole width should be used—this can be facilitated by using a dense horizontal line-scanning protocol or using 
multiple radial scans.  
3 
 
 
Abbreviations: ELM, exterior limiting membrane; ERM, epiretinal membrane; ETDRS, Early Treatment Diabetic Retinopathy Study, ILM, inner limiting 
membrane; IS, inner segment; OCT, optical coherence tomography; OS, outer segment; RPE, retinal pigment epithelium; SRF, subretinal fluid; VMA, 
vitreomacular adhesion; VMT, vitreomacular traction. 
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Table 2 Fleiss’ kappa values 
 
a. Initial test set of 26 images.  
 Fleiss’ kappa 95% confidence 
interval 
Vitreoretinal interface 0.61 0.55−0.67 
Shape 0.71 0.65−0.76 
Presence of RPE abnormality 0.78 0.71−0.85 
Inner retina 0.63 0.55−0.71 
Outer retina 0.71 0.66−0.76 
 
b. Final test set of 10 images.  
 Fleiss’ kappa 95% confidence 
interval 
Vitreoretinal interface 0.81 0.75−0.86 
Shape 0.82 0.74−0.88 
Presence of RPE abnormality 0.76 0.71−0.81 
Inner retina 0.95 0.91−0.99 
Outer retina 0.79 0.73−0.85 
Abbreviations: RPE, retinal pigment epithelium. 
 
 
